We are live on ! Find out more
AEMD icon

Aethlon Medical

12 hedge funds and large institutions have $959K invested in Aethlon Medical in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1212 (0)

0% more ownership

Funds ownership: 0%0% (+0%)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

38% less capital invested

Capital invested by funds: $1.54M → $959K (-$576K)

Holders
12
Holders Change
Holders Change %
0%
% of All Funds
0.26%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
2
Reduced
Closed
4
Calls
Puts
Net Calls
Net Calls Change

AEMD Hedge Fund Activity: Q1 2019 in Review

12 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q1 2019, worth a combined $959K — down 38% from $1.54M a quarter earlier.

Fund positioning in AEMD was balanced in Q1 2019: 4 funds opened new positions, 4 closed out, 2 added to existing stakes and 0 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $85K. The largest seller was Bank of New York Mellon, exiting entirely with an estimated $50K sold.

  • 12 institutional investors held Aethlon Medical (AEMD) as of Q1 2019, unchanged from Q4 2018.
  • Funds reported $959K of Aethlon Medical stock for Q1 2019, down 38% quarter-over-quarter.
  • 4 funds opened new Aethlon Medical positions in Q1 2019 and 4 closed out, a net change of 0 holders.
  • The largest Aethlon Medical buyer in Q1 2019 was Geode Capital Management, an estimated $85K added.
  • The largest Aethlon Medical seller in Q1 2019 was Bank of New York Mellon, an estimated $50K sold.

Based on aggregated 13F filings for Q1 2019.